Genmab A/S

World Rank (Jul-30-2023)

718

Market Cap (Jul-30-2023)

26.119 Billion USD

World Rank (Dec-25-2022)

605

Market Cap (Dec-25-2022)

28.320 Billion USD

World Rank (Jan-07-2022)

883

Market Cap (Jan-07-2022)

23.695 Billion USD

World Rank (Jan-01-2021)

696

Market Cap (Jan-01-2021)

26.503 Billion USD

Annual Revenue in USD

2,157 Million USD

Annual Net Income in USD

816 Million USD

Total Assets in USD

4,476 Million USD

Total Liabilities in USD

419 Million USD

Annual Results for Year ending in

Dec-2022 month

Headquarters Country

Company Business

Stock Category

Stock Exchange

Company Rank in Country in 2022

Company Rank in Denmark in 2022 is 8

Number of Employees

1,660

Employee Count as on Date

As on 2022

CEO:

Jan G. J. van de Winkel

Yahoo

Yahoo @ Copenhagen

Wikipedia

Company Website:

GENMAB A/S

About Company Business:

Genmab is an international biotechnology company specializing in the creation and development of differentiated antibody therapeutics for the treatment of cancer. Headquarters is in Denmark.

Founded Year

1999

Annual Results Summary:

GENMAB A/S - Yearly Revenue and Net Income - in Million DKK:

Year - Ending	Revenue	Operating Income	Net Income
Dec-2022	14,595	6,357	5,522
Dec-2021	8,482	3,018	3,008
Dec-2020	10,111	6,313	4,758
Dec-2019	5,366	2,638	2,166

Balance Sheet Summary

Total Assets as on Dec-2022 was 30,278 Million DKK.

Total Liabilities as on Dec-2022 was 2,837 Million DKK.

Total Equity as on Dec-2022 was 27,441 Million DKK.

Genmab A/S

GENMAB A/S - Yearly Revenue and Net Income - in Million DKK:

Share it on Social Media